Christopher P. Lowe - Jun 28, 2021 Form 4 Insider Report for Cortexyme, Inc. (QNCX)

Signature
/s/ Caryn McDowell, Attorney-in-Fact for Christopher Lowe
Stock symbol
QNCX
Transactions as of
Jun 28, 2021
Transactions value $
-$971,574
Form type
4
Date filed
6/30/2021, 05:46 PM
Previous filing
May 14, 2021
Next filing
Jun 30, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction QNCX Common Stock Options Exercise $44.6K +20K $2.23 20K Jun 28, 2021 Direct
transaction QNCX Common Stock Sale -$412K -7.72K -38.62% $53.39 12.3K Jun 28, 2021 Direct F1, F2
transaction QNCX Common Stock Sale -$383K -7.08K -57.67% $54.13 5.2K Jun 28, 2021 Direct F1, F3
transaction QNCX Common Stock Sale -$229K -4.15K -79.91% $55.11 1.04K Jun 28, 2021 Direct F1, F4
transaction QNCX Common Stock Sale -$58.6K -1.04K -100% $56.16 0 Jun 28, 2021 Direct F1, F5
transaction QNCX Common Stock Options Exercise $66.9K +30K $2.23 30K Jun 30, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction QNCX Stock Option (right to buy) Options Exercise $0 -20K -8.49% $0.00 216K Jun 28, 2021 Common Stock 20K $2.23 Direct F6
transaction QNCX Stock Option (right to buy) Options Exercise $0 -30K -13.93% $0.00 185K Jun 30, 2021 Common Stock 30K $2.23 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.64 to $53.63, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.64 to $54.61, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.66 to $55.36, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.73 to $56.71, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F6 The option will vest as to 25% of the shares on November 15, 2019, with the remaining 75% of shares vesting in equal monthly installments beginning on December 15, 2019 and ending on November 15, 2022.